Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VCEL
VCEL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VCEL News
Cell Therapy Market Set to Nearly Double by 2035
Apr 06 2026
Newsfilter
Vericel Secures $197M Contract with U.S. BARDA
Apr 02 2026
seekingalpha
Vericel Secures $197 Million BARDA Contract
Apr 02 2026
Newsfilter
MediWound Reports $197 Million BARDA Contract Award to Vericel for NexoBrid
Apr 02 2026
Newsfilter
Vericel Receives Approval for MACI Commercial Production
Mar 04 2026
Newsfilter
Vericel Corporation to Present at Upcoming Investor Conferences
Mar 03 2026
Newsfilter
Vericel Corporation Reports Strong Q4 2025 Earnings with Record Revenue Growth
Feb 26 2026
seekingalpha
Vericel Reports Significant Earnings Growth in Q4
Feb 26 2026
NASDAQ.COM
Vericel Q4 Earnings Exceed Expectations with Strong Revenue Growth
Feb 26 2026
seekingalpha
Vericel Scheduled to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Vericel Corporation (VCEL) Expects $276 Million Revenue in 2025 with Continued Profitability
Jan 13 2026
Benzinga
VCEL Stock Shows Significant Volatility with 52-Week High of $63
Jan 06 2026
NASDAQ.COM
American Express and Snowflake See Significant Options Trading Volume Surge
Dec 26 2025
NASDAQ.COM
Inaugural Week of VCEL Options Trading for February 2026
Dec 19 2025
NASDAQ.COM
Vericel Scheduled to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
Nov 14 2025
Newsfilter
Truist Reduces Price Target for Vericel Corporation (VCEL) from $46 to $41
Oct 21 2025
Yahoo Finance
Show More News
